A Comprehensive Report for decision making

Drug Developer's Intelligence Report

Oncology DRUG REPORT

2020

This Report is only Available on request...

Kindly Check the Latest Updated Report of this Series

RELEASED - FEB 2020

1610

Oncology Drug Developers

It is an excellent report that has a wide variety of oncology information all in one place.

- Dr. Oleh Denysyk

Fourth Updated Edition in oncology Drug Development Intelligence Series

Report Cover all Aspects of Cancer Drug Development Intelligence

COMPANIES * MOLECULES * INDICATIONS * TECHNOLOGIES * DEALS * FUNDING

OI 2020 Vs OI 2017
(in terms of Oncology Drug Developers Number)

UPDATED DATA for
ACCURATE DECISIONS

 

ODR 2020 is a key update over previous report OI 2017, as it may covers 220 more oncology drug developers than the previous report. It also abandoned 103 companies, which were earlier covered in OI 2014, which were either acquired/merged or closed during the period.

largest coverage

providing intelligence at fingertips

1
Countries

Largest Coverage with 32 Countries covered Globally

1
Drug developers

523 Clinical, 360 Preclinical Companies Profiles

1 +
Molecules

Individual Drug Mechanism of Action & Drug Target

1 +
Cancer Targets

Emerging Cancer Drug Targets Details

intelligence supercharged

1055 pages full of insights

Other Reports in this series

For Purchase, Kindly check the latest report available in this series...

Oncology Intelligence 2013
Comprehensive Decision Making Intelligence derived from Active 624 Oncology Drug Developers.
Oncology Drug Report 2014
Comprehensive Decision Making Intelligence derived from Active 931 Oncology Drug Developers.
Oncology Drug Report 2017
Comprehensive Decision Making Intelligence derived from Active 1047 Oncology Drug Developers.
Oncology Drug Report 2020
Comprehensive Decision Making Intelligence derived from Active 1610 Oncology Drug Developers.
Oncology Drug Report 2021
Comprehensive Decision Making Intelligence derived from Active 2010 Oncology Drug Developers.
Oncology Drug Report 2022
Upcoming Comprehensive Decision Making Report derived from Active 2300+ Oncology Drug Developers.
January 2013
March 2014
January 2017
Feburary 2020
May 2021
March 2022